Biotechnology
The Biotechnology industry has a total of 588 stocks, with a combined market cap of $1.29 trillion and total revenue of $115.83 billion.
Market Cap
1.29T
Revenue
115.83B
Profits
-36.06B
PE Ratio
n/a
Profit Margin
-31.13%
Dividend Yield
0.04%
588 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 132.51B | -0.74% | 1,150,396 | 12.59B |
| 2 | MRNA | Moderna, Inc. | 76.88B | -5.35% | 20,649,484 | 2.23B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 75.72B | 1.03% | 872,412 | 15.53B |
| 4 | ARGX | argenx SE | 60.14B | -1.21% | 243,738 | 5.32B |
| 5 | RVMD | Revolution Medicines, Inc. | 43.99B | 0.38% | 1,845,705 | - |
| 6 | ONC | BeOne Medicines AG | 41.61B | 0.18% | 328,876 | 6.13B |
| 7 | ALNY | Alnylam Pharmaceuticals, Inc. | 33.02B | -2.89% | 1,044,385 | 4.80B |
| 8 | ROIV | Roivant Sciences Ltd. | 26.42B | 0.19% | 5,282,288 | 7.53M |
| 9 | RPRX | Royalty Pharma plc | 25.92B | 0.24% | 3,652,813 | 2.54B |
| 10 | INSM | Insmed Incorporated | 24.93B | -1.29% | 2,870,339 | 1.14B |
| 11 | BNTX | BioNTech SE | 24.69B | -0.27% | 807,429 | 3.03B |
| 12 | INCY | Incyte Corporation | 24.60B | -1.50% | 1,619,766 | 5.82B |
| 13 | GMAB | Genmab A/S | 21.27B | 0.30% | 5,154,549 | 4.13B |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 15.03B | -0.36% | 1,005,233 | 4.60B |
| 15 | ASND | Ascendis Pharma A/S | 14.96B | -0.11% | 926,226 | 1.20B |
| 16 | EXEL | Exelixis, Inc. | 14.47B | -0.41% | 3,065,021 | 2.44B |
| 17 | SMMT | Summit Therapeutics Inc. | 13.49B | 3.17% | 13,060,230 | - |
| 18 | BBIO | BridgeBio Pharma, Inc. | 12.86B | -0.26% | 2,822,373 | 713.07M |
| 19 | HALO | Halozyme Therapeutics, Inc. | 12.53B | -1.04% | 3,544,775 | 1.66B |
| 20 | CORT | Corcept Therapeutics Incorporated | 12.46B | 0.43% | 910,306 | 830.81M |
| 21 | TWST | Twist Bioscience Corporation | 12.12B | 3.82% | 3,252,447 | 431.80M |
| 22 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.64B | -1.10% | 262,461 | 1.28B |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 11.61B | 0.22% | 1,797,859 | 3.41B |
| 24 | TECH | Bio-Techne Corporation | 11.36B | 0.12% | 3,138,620 | 1.22B |
| 25 | IBRX | ImmunityBio, Inc. | 10.00B | 6.91% | 27,287,318 | 165.79M |
| 26 | KRYS | Krystal Biotech, Inc. | 9.84B | -0.75% | 268,263 | 440.48M |
| 27 | AXSM | Axsome Therapeutics, Inc. | 9.66B | -0.94% | 1,033,880 | 776.57M |
| 28 | KYMR | Kymera Therapeutics, Inc. | 9.30B | 1.16% | 1,022,617 | 105.00M |
| 29 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.25B | -1.21% | 1,742,744 | 669.50M |
| 30 | CYTK | Cytokinetics, Incorporated | 9.16B | 0.41% | 2,977,676 | 67.67M |
| 31 | PTGX | Protagonist Therapeutics, Inc. | 9.12B | -0.06% | 787,656 | 281.99M |
| 32 | ABVX | ABIVAX Société Anonyme | 8.69B | 0.53% | 886,096 | 5.33M |
| 33 | CAI | Caris Life Sciences, Inc. | 8.66B | -2.92% | 2,929,545 | 989.61M |
| 34 | PCVX | Vaxcyte, Inc. | 8.47B | 0.37% | 1,508,716 | - |
| 35 | PRAX | Praxis Precision Medicines, Inc. | 8.13B | 3.64% | 710,545 | 7.46M |
| 36 | TGTX | TG Therapeutics, Inc. | 7.91B | -0.73% | 1,908,210 | 799.54M |
| 37 | SYRE | Spyre Therapeutics, Inc. | 7.85B | 5.09% | 2,096,049 | - |
| 38 | IONS | Ionis Pharmaceuticals, Inc. | 7.42B | -2.70% | 2,630,165 | 874.09M |
| 39 | IMVT | Immunovant, Inc. | 6.98B | 0.96% | 1,433,913 | - |
| 40 | BLTE | Belite Bio, Inc | 6.84B | 1.90% | 142,076 | - |
| 41 | IOVA | Iovance Biotherapeutics, Inc. | 6.71B | 2.56% | 29,341,483 | 324.97M |
| 42 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.56B | -0.52% | 737,177 | 239.92M |
| 43 | CGON | CG Oncology, Inc. | 6.28B | 0.52% | 1,330,926 | 6.23M |
| 44 | LGND | Ligand Pharmaceuticals Incorporated | 6.23B | 0.65% | 505,859 | 290.54M |
| 45 | KOD | Kodiak Sciences Inc. | 5.95B | 4.04% | 4,919,999 | - |
| 46 | SRRK | Scholar Rock Holding Corporation | 5.88B | 1.19% | 1,285,058 | - |
| 47 | COGT | Cogent Biosciences, Inc. | 5.56B | 1.14% | 1,960,159 | - |
| 48 | MIRM | Mirum Pharmaceuticals, Inc. | 5.55B | -2.35% | 901,728 | 618.07M |
| 49 | TVTX | Travere Therapeutics, Inc. | 5.55B | -1.85% | 1,560,540 | 591.33M |
| 50 | ORKA | Oruka Therapeutics, Inc. | 5.51B | 1.39% | 1,535,618 | - |
| 51 | PTCT | PTC Therapeutics, Inc. | 5.41B | -0.28% | 1,043,320 | 1.01B |
| 52 | CRSP | CRISPR Therapeutics AG | 5.35B | -1.21% | 1,169,341 | 13.39M |
| 53 | ERAS | Erasca, Inc. | 5.13B | 3.17% | 5,286,619 | - |
| 54 | DFTX | Definium Therapeutics, Inc. | 5.11B | -0.39% | 2,380,945 | - |
| 55 | MANE | Veradermics, Incorporated | 5.07B | 2.89% | 689,721 | - |
| 56 | DNTH | Dianthus Therapeutics, Inc. | 4.93B | 1.02% | 1,030,793 | 1.90M |
| 57 | ABCL | AbCellera Biologics Inc. | 4.73B | -1.55% | 4,863,812 | 66.17M |
| 58 | EWTX | Edgewise Therapeutics, Inc. | 4.41B | 3.60% | 1,678,337 | - |
| 59 | TNGX | Tango Therapeutics, Inc. | 4.21B | 2.17% | 3,660,636 | 53.81M |
| 60 | RLAY | Relay Therapeutics, Inc. | 3.96B | -1.69% | 2,782,450 | 10.35M |
| 61 | PBLS | Parabilis Medicines, Inc. | 3.94B | 1.19% | 547,139 | 148.00K |
| 62 | CELC | Celcuity Inc. | 3.89B | 2.77% | 2,555,370 | - |
| 63 | LEGN | Legend Biotech Corporation | 3.85B | 5.69% | 2,955,980 | 1.27B |
| 64 | VKTX | Viking Therapeutics, Inc. | 3.80B | 2.48% | 7,000,075 | - |
| 65 | TLX | Telix Pharmaceuticals Limited | 3.71B | -3.26% | 344,213 | 890.79M |
| 66 | IDYA | IDEAYA Biosciences, Inc. | 3.71B | 1.48% | 1,016,437 | 234.13M |
| 67 | XENE | Xenon Pharmaceuticals Inc. | 3.60B | -0.16% | 2,466,476 | 7.50M |
| 68 | ACAD | Acadia Pharmaceuticals Inc. | 3.47B | -0.35% | 3,133,998 | 1.14B |
| 69 | TARS | Tarsus Pharmaceuticals, Inc. | 3.45B | 2.50% | 1,562,865 | 606.33M |
| 70 | ELVN | Enliven Therapeutics, Inc. | 3.36B | -1.44% | 800,168 | - |
| 71 | ARQT | Arcutis Biotherapeutics, Inc. | 3.32B | -1.20% | 2,391,395 | 463.98M |
| 72 | DNLI | Denali Therapeutics Inc. | 3.30B | -0.67% | 2,255,580 | 3.60M |
| 73 | RCUS | Arcus Biosciences, Inc. | 3.29B | 0.70% | 1,361,916 | 117.00M |
| 74 | PGEN | Precigen, Inc. | 3.06B | 6.34% | 11,685,477 | 85.72M |
| 75 | DYN | Dyne Therapeutics, Inc. | 3.01B | -0.62% | 4,456,454 | - |
| 76 | ZLAB | Zai Lab Limited | 2.96B | 1.58% | 830,830 | 449.61M |
| 77 | NAMS | NewAmsterdam Pharma Company N.V. | 2.91B | 2.14% | 2,270,415 | 7.12M |
| 78 | MBX | MBX Biosciences, Inc. | 2.82B | 1.51% | 523,792 | - |
| 79 | CLDX | Celldex Therapeutics, Inc. | 2.55B | 2.43% | 2,502,809 | 158.00K |
| 80 | IRON | Disc Medicine, Inc. | 2.51B | -0.62% | 671,486 | - |
| 81 | SLS | SELLAS Life Sciences Group, Inc. | 2.49B | 6.95% | 8,618,722 | - |
| 82 | NRIX | Nurix Therapeutics, Inc. | 2.46B | 0.13% | 2,010,648 | 36.77M |
| 83 | BEAM | Beam Therapeutics Inc. | 2.44B | -0.29% | 1,559,094 | 156.04M |
| 84 | IMNM | Immunome, Inc. | 2.44B | -1.74% | 1,305,966 | 4.02M |
| 85 | VRDN | Viridian Therapeutics, Inc. | 2.33B | 2.95% | 1,404,824 | 71.13M |
| 86 | VERA | Vera Therapeutics, Inc. | 2.33B | -0.28% | 1,800,090 | - |
| 87 | HRMY | Harmony Biosciences Holdings, Inc. | 2.29B | -0.08% | 667,624 | 959.90M |
| 88 | ADMA | ADMA Biologics, Inc. | 2.25B | 0.70% | 2,699,041 | 512.28M |
| 89 | GPCR | Structure Therapeutics Inc. | 2.23B | -4.34% | 2,197,289 | - |
| 90 | PHVS | Pharvaris N.V. | 2.23B | -0.03% | 839,836 | - |
| 91 | MLYS | Mineralys Therapeutics, Inc. | 2.22B | 2.66% | 2,051,832 | - |
| 92 | RXRX | Recursion Pharmaceuticals, Inc. | 2.21B | 2.48% | 32,785,908 | 54.86M |
| 93 | AUPH | Aurinia Pharmaceuticals Inc. | 2.15B | -1.37% | 913,838 | 311.51M |
| 94 | ADRX | ADARx Pharmaceuticals, Inc. | 2.13B | -3.39% | 788,117 | 6.13M |
| 95 | NKTR | Nektar Therapeutics | 2.07B | 2.20% | 1,209,695 | 54.59M |
| 96 | VCEL | Vericel Corporation | 2.06B | -1.16% | 585,376 | 306.30M |
| 97 | TRVI | Trevi Therapeutics, Inc. | 2.04B | -0.69% | 2,725,666 | - |
| 98 | BHVN | Biohaven Ltd. | 2.02B | 0.45% | 1,432,112 | - |
| 99 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.99B | 0.13% | 3,606,275 | 208.78M |
| 100 | PVLA | Palvella Therapeutics, Inc. | 1.99B | -0.77% | 262,228 | - |
| 101 | URGN | UroGen Pharma Ltd. | 1.99B | 0.44% | 641,377 | 188.73M |
| 102 | AGIO | Agios Pharmaceuticals, Inc. | 1.99B | -0.15% | 1,548,455 | 98.34M |
| 103 | NUVB | Nuvation Bio Inc. | 1.97B | -0.36% | 5,549,289 | 169.90M |
| 104 | LKFT | Lakefront Biotherapeutics NV | 1.95B | 0.34% | 188,588 | 1.13B |
| 105 | GENB | Generate Biomedicines, Inc. | 1.93B | -2.59% | 733,194 | 26.48M |
| 106 | SRPT | Sarepta Therapeutics, Inc. | 1.92B | -2.25% | 1,995,000 | 1.97B |
| 107 | MESO | Mesoblast Limited | 1.91B | -1.48% | 199,071 | 120.25M |
| 108 | FTRE | Fortrea Holdings Inc. | 1.90B | 1.06% | 1,480,952 | 2.68B |
| 109 | VIR | Vir Biotechnology, Inc. | 1.89B | 4.98% | 1,737,524 | 303.23M |
| 110 | ZYME | Zymeworks Inc. | 1.88B | -2.61% | 1,585,031 | 37.13M |
| 111 | XNCR | Xencor, Inc. | 1.86B | -0.20% | 1,541,989 | 104.97M |
| 112 | ABSI | Absci Corporation | 1.85B | 6.21% | 5,432,372 | 1.56M |
| 113 | SEPN | Septerna, Inc. | 1.83B | - | 209,578 | 98.88M |
| 114 | NVAX | Novavax, Inc. | 1.78B | -0.09% | 4,565,359 | 413.80M |
| 115 | ZBIO | Zenas BioPharma, Inc. | 1.76B | 0.78% | 623,231 | 1.00M |
| 116 | NTLA | Intellia Therapeutics, Inc. | 1.69B | 0.25% | 5,318,300 | 59.51M |
| 117 | OCUL | Ocular Therapeutix, Inc. | 1.68B | -2.54% | 4,569,910 | 52.06M |
| 118 | SNDX | Syndax Pharmaceuticals, Inc. | 1.68B | 3.10% | 1,725,782 | 252.25M |
| 119 | STOK | Stoke Therapeutics, Inc. | 1.68B | 0.46% | 1,874,751 | 27.59M |
| 120 | QURE | uniQure N.V. | 1.68B | -1.43% | 7,443,135 | 18.67M |
| 121 | RAPP | Rapport Therapeutics, Inc. | 1.61B | 1.76% | 582,026 | 20.00M |
| 122 | GHRS | GH Research PLC | 1.61B | -4.82% | 384,715 | - |
| 123 | NBTX | Nanobiotix S.A. | 1.59B | -0.22% | 311,349 | 13.15M |
| 124 | TSHA | Taysha Gene Therapies, Inc. | 1.59B | -2.40% | 3,901,850 | 5.49M |
| 125 | IMCR | Immunocore Holdings plc | 1.56B | -1.82% | 622,914 | 430.78M |
| 126 | INVA | Innoviva, Inc. | 1.53B | 0.47% | 1,100,216 | 440.00M |
| 127 | MAZE | Maze Therapeutics, Inc. | 1.51B | 0.59% | 518,007 | 20.00M |
| 128 | RARE | Ultragenyx Pharmaceutical Inc. | 1.51B | -1.89% | 4,422,692 | 717.00M |
| 129 | ANAB | AnaptysBio, Inc. | 1.50B | -0.22% | 1,430,097 | 106.09M |
| 130 | TYRA | Tyra Biosciences, Inc. | 1.50B | -0.59% | 1,034,672 | - |
| 131 | AVBP | ArriVent BioPharma, Inc. | 1.49B | 2.51% | 712,456 | - |
| 132 | KLRA | Kailera Therapeutics, Inc. | 1.48B | 3.91% | 1,368,804 | - |
| 133 | KRSA | Korsana Biosciences, Inc. | 1.47B | -4.87% | 121,131 | - |
| 134 | INBX | Inhibrx Biosciences, Inc. | 1.47B | -4.53% | 389,471 | 1.30M |
| 135 | AAPG | Ascentage Pharma Group International | 1.44B | 6.25% | 13,711 | 94.61M |
| 136 | COAG | Hemab Therapeutics Holdings, Inc. | 1.44B | -5.46% | 865,203 | - |
| 137 | ORIC | ORIC Pharmaceuticals, Inc. | 1.40B | 0.75% | 1,960,837 | - |
| 138 | KARD | Kardigan, Inc. | 1.38B | 0.61% | 487,834 | - |
| 139 | OMER | Omeros Corporation | 1.38B | -1.09% | 1,365,733 | 38.42M |
| 140 | DRTS | Alpha Tau Medical Ltd. | 1.38B | -1.84% | 369,266 | - |
| 141 | BRVE | Braveheart Bio, Inc. | 1.32B | -9.58% | 967,620 | - |
| 142 | DMRA | Damora Therapeutics, Inc. | 1.31B | 3.00% | 562,948 | - |
| 143 | SVRA | Savara Inc. | 1.31B | 1.57% | 6,051,741 | - |
| 144 | TRAX | First Tracks Biotherapeutics, Inc. | 1.27B | -1.50% | 610,639 | - |
| 145 | AVLN | Avalyn Pharma Inc. | 1.27B | 5.35% | 347,615 | - |
| 146 | MNKD | MannKind Corporation | 1.25B | 16.77% | 15,020,194 | 393.63M |
| 147 | REPL | Replimune Group, Inc. | 1.25B | 1.85% | 3,081,734 | - |
| 148 | LBRX | LB Pharmaceuticals Inc | 1.24B | 2.92% | 437,194 | - |
| 149 | BCAX | Bicara Therapeutics Inc. | 1.23B | 0.27% | 905,369 | - |
| 150 | IMTX | Immatics N.V. | 1.20B | 2.57% | 1,898,899 | 47.65M |
| 151 | VOR | Vor Biopharma Inc. | 1.13B | 4.09% | 1,069,907 | - |
| 152 | LTGO | Latigo Biotherapeutics, Inc. | 1.11B | -7.79% | 532,592 | - |
| 153 | AKTS | Aktis Oncology, Inc. | 1.08B | -1.12% | 277,271 | 10.06M |
| 154 | SPTX | Seaport Therapeutics, Inc. | 1.08B | 8.03% | 488,678 | - |
| 155 | ODTX | Odyssey Therapeutics, Inc. | 1.06B | -0.98% | 334,165 | 99.00K |
| 156 | MGTX | MeiraGTx Holdings plc | 1.06B | -1.17% | 1,423,924 | 397.50M |
| 157 | JANX | Janux Therapeutics, Inc. | 1.06B | 1.95% | 772,483 | 24.00M |
| 158 | ANL | Adlai Nortye Group Ltd. | 1.03B | 2.24% | 93,946 | 18.06M |
| 159 | GLUE | Monte Rosa Therapeutics, Inc. | 1.02B | 1.62% | 913,958 | 28.73M |
| 160 | ANRO | Alto Neuroscience, Inc. | 1.00B | -3.95% | 891,623 | - |
| 161 | MLTX | MoonLake Immunotherapeutics | 995.75M | 2.18% | 1,994,434 | - |
| 162 | CGEM | Cullinan Therapeutics, Inc. | 987.84M | 0.79% | 1,067,166 | - |
| 163 | SLBT | SL Science Holding Limited | 969.45M | -7.10% | 27,303 | 3.27M |
| 164 | CRVS | Corvus Pharmaceuticals, Inc. | 969.07M | -2.04% | 875,837 | - |
| 165 | ALMS | Alumis Inc. | 956.53M | 1.37% | 1,402,796 | 7.40M |
| 166 | KURA | Kura Oncology, Inc. | 952.77M | -0.88% | 1,871,390 | 77.23M |
| 167 | ABUS | Arbutus Biopharma Corporation | 945.71M | 1.92% | 16,876,009 | 181.72M |
| 168 | APMD | Apnimed, Inc. | 912.13M | -8.33% | 668,810 | 115.12M |
| 169 | RIGL | Rigel Pharmaceuticals, Inc. | 899.44M | -1.51% | 252,210 | 276.79M |
| 170 | HELP | Cybin Inc. | 897.91M | -3.23% | 823,389 | - |
| 171 | JBIO | Jade Biosciences, Inc. | 892.91M | -0.99% | 930,920 | - |
| 172 | IVA | Inventiva S.A. | 884.11M | 12.16% | 4,802,651 | 2.81M |
| 173 | SANA | Sana Biotechnology, Inc. | 872.64M | 0.17% | 3,245,614 | - |
| 174 | SGP | SpyGlass Pharma, Inc. | 867.64M | 1.97% | 79,568 | - |
| 175 | DNA | Ginkgo Bioworks Holdings, Inc. | 863.98M | 7.27% | 4,643,485 | 132.42M |
| 176 | ARDX | Ardelyx, Inc. | 852.22M | 0.88% | 4,412,507 | 450.89M |
| 177 | OBX | Obsidian Therapeutics, Inc. | 845.05M | -6.17% | 351,595 | - |
| 178 | LXRX | Lexicon Pharmaceuticals, Inc. | 834.29M | -0.27% | 1,744,112 | 41.47M |
| 179 | ACHV | Achieve Life Sciences, Inc. | 832.48M | 5.20% | 2,378,182 | - |
| 180 | AVTX | Avalo Therapeutics, Inc. | 822.15M | -1.60% | 1,432,710 | 59.00K |
| 181 | ANNX | Annexon, Inc. | 801.92M | 2.42% | 4,411,914 | - |
| 182 | CADL | Candel Therapeutics, Inc. | 798.85M | -4.04% | 1,268,824 | - |
| 183 | FDMT | 4D Molecular Therapeutics, Inc. | 790.54M | -1.24% | 1,037,031 | 92.01M |
| 184 | GERN | Geron Corporation | 790.24M | -0.81% | 9,443,026 | 204.56M |
| 185 | DSGN | Design Therapeutics, Inc. | 786.65M | -0.40% | 589,520 | - |
| 186 | ATTO | Attovia Therapeutics, Inc. | 781.55M | -5.73% | 769,466 | 1.80M |
| 187 | GYRE | Gyre Therapeutics, Inc. | 777.23M | 0.14% | 159,787 | 109.82M |
| 188 | SLDB | Solid Biosciences Inc. | 775.24M | 0.98% | 1,711,183 | - |
| 189 | ACRS | Aclaris Therapeutics, Inc. | 774.27M | -0.38% | 2,263,469 | 8.22M |
| 190 | FTH | Faeth Therapeutics, Inc. | 768.49M | 5.95% | 356,522 | - |
| 191 | OLMA | Olema Pharmaceuticals, Inc. | 755.98M | 1.17% | 1,542,714 | - |
| 192 | IMMX | Immix Biopharma, Inc. | 744.37M | -1.28% | 2,408,955 | - |
| 193 | WVE | Wave Life Sciences, Inc. | 729.08M | 1.65% | 4,209,214 | 65.37M |
| 194 | VSTM | Verastem, Inc. | 729.04M | 1.64% | 1,568,511 | 87.53M |
| 195 | OABI | OmniAb, Inc. | 721.14M | 4.64% | 1,928,626 | 38.46M |
| 196 | PHAR | Pharming Group N.V. | 713.09M | -0.20% | 12,310 | 366.48M |
| 197 | ETRA | Electra Therapeutics, Inc. | 706.13M | -0.88% | 925,698 | - |
| 198 | DBVT | DBV Technologies S.A. | 696.94M | 1.82% | 400,953 | 5.04M |
| 199 | NVCT | Nuvectis Pharma, Inc. | 691.22M | 3.34% | 240,271 | - |
| 200 | STTK | Shattuck Labs, Inc. | 684.48M | 4.28% | 3,356,719 | 1.00M |
| 201 | MDXG | MiMedx Group, Inc. | 677.06M | -0.54% | 1,028,489 | 355.17M |
| 202 | CLYM | Climb Bio, Inc. | 658.79M | -0.26% | 1,411,159 | - |
| 203 | SLN | Silence Therapeutics plc | 658.09M | 1.20% | 1,356,281 | 615.00K |
| 204 | ZVRA | Zevra Therapeutics, Inc. | 651.44M | -3.26% | 1,818,332 | 136.07M |
| 205 | AURA | Aura Biosciences, Inc. | 651.27M | 2.11% | 677,457 | - |
| 206 | CBIO | Crescent Biopharma, Inc. | 624.47M | -1.15% | 289,530 | 11.88M |
| 207 | SGMT | Sagimet Biosciences Inc. | 614.13M | 5.89% | 5,453,770 | - |
| 208 | CRMD | CorMedix Inc. | 600.17M | -2.90% | 948,361 | 462.25M |
| 209 | CTMX | CytomX Therapeutics, Inc. | 592.69M | -1.09% | 3,220,695 | 18.30M |
| 210 | BLSM | BlossomHill Therapeutics, Inc. | 592.47M | -12.77% | 359,739 | - |
| 211 | VALN | Valneva SE | 583.63M | 0.81% | 5,502 | 163.30M |
| 212 | PHAT | Phathom Pharmaceuticals, Inc. | 579.84M | -0.82% | 809,128 | 239.66M |
| 213 | OCS | Oculis Holding AG | 576.58M | 2.30% | 434,681 | 1.45M |
| 214 | MPLT | MapLight Therapeutics, Inc. | 564.65M | 0.10% | 303,254 | - |
| 215 | NGNE | Neurogene Inc. | 556.72M | -2.01% | 160,123 | 925.00K |
| 216 | ALT | Altimmune, Inc. | 556.32M | -3.70% | 4,922,486 | 31.00K |
| 217 | ALLO | Allogene Therapeutics, Inc. | 552.79M | -1.23% | 8,132,422 | 4.64M |
| 218 | EPRX | Eupraxia Pharmaceuticals Inc. | 550.58M | 9.51% | 1,279,348 | - |
| 219 | CAPR | Capricor Therapeutics, Inc. | 550.58M | 10.50% | 20,566,626 | 11.13M |
| 220 | AGMB | AgomAb Therapeutics NV | 546.65M | 5.41% | 133,705 | - |
| 221 | PRME | Prime Medicine, Inc. | 543.50M | -1.13% | 3,132,452 | 4.07M |
| 222 | MNPR | Monopar Therapeutics Inc. | 534.76M | -0.41% | 226,311 | - |
| 223 | YDES | YD Bio Limited | 525.57M | -2.50% | 205,694 | 1.24M |
| 224 | AUTL | Autolus Therapeutics plc | 516.36M | 4.30% | 1,159,350 | 117.39M |
| 225 | PBYI | Puma Biotechnology, Inc. | 512.59M | 1.53% | 398,840 | 231.24M |
| 226 | ARVN | Arvinas, Inc. | 505.76M | 3.13% | 1,061,018 | 316.70M |
| 227 | CTNM | Contineum Therapeutics, Inc. | 504.88M | 16.70% | 1,597,697 | - |
| 228 | ENTX | Entera Bio Ltd. | 503.84M | 8.18% | 520,976 | 42.00K |
| 229 | PROK | ProKidney Corp. | 501.86M | 1.84% | 1,196,603 | 818.00K |
| 230 | RGNX | REGENXBIO Inc. | 497.08M | 1.07% | 1,788,566 | 174.48M |
| 231 | DRUG | Bright Minds Biosciences Inc. | 488.67M | 0.16% | 79,316 | - |
| 232 | OVID | Ovid Therapeutics Inc. | 486.29M | -1.97% | 1,442,644 | 1.58M |
| 233 | ASMB | Assembly Biosciences, Inc. | 478.27M | 0.04% | 221,116 | 74.85M |
| 234 | TECX | Tectonic Therapeutic, Inc. | 455.30M | -0.21% | 251,630 | - |
| 235 | AGEN | Agenus Inc. | 447.05M | 0.40% | 1,367,005 | 132.69M |
| 236 | DMAC | DiaMedica Therapeutics Inc. | 445.97M | 0.85% | 219,106 | - |
| 237 | EIKN | Eikon Therapeutics, Inc. | 434.40M | 1.39% | 585,743 | - |
| 238 | RZLT | Rezolute, Inc. | 434.27M | 1.22% | 1,702,779 | - |
| 239 | PRTA | Prothena Corporation plc | 430.20M | -4.56% | 634,778 | 54.53M |
| 240 | TTRX | Turn Therapeutics Inc. | 428.65M | 7.31% | 88,709 | - |
| 241 | SPRY | ARS Pharmaceuticals, Inc. | 428.62M | -2.05% | 1,298,236 | 116.93M |
| 242 | KYTX | Kyverna Therapeutics, Inc. | 420.54M | -0.58% | 746,992 | - |
| 243 | AVIR | Atea Pharmaceuticals, Inc. | 417.87M | 0.58% | 296,264 | - |
| 244 | CCCC | C4 Therapeutics, Inc. | 409.67M | 6.39% | 2,609,340 | 35.04M |
| 245 | PRLD | Prelude Therapeutics Incorporated | 402.71M | -1.26% | 703,218 | 22.42M |
| 246 | IRD | Opus Genetics, Inc. | 402.67M | -2.32% | 2,458,477 | 9.86M |
| 247 | RLMD | Relmada Therapeutics, Inc. | 402.15M | 1.07% | 999,518 | - |
| 248 | ZURA | Zura Bio Limited | 398.65M | 4.00% | 3,325,525 | - |
| 249 | EDIT | Editas Medicine, Inc. | 394.70M | -0.77% | 1,625,840 | 47.01M |
| 250 | GALT | Galectin Therapeutics Inc. | 391.30M | -0.77% | 198,061 | - |
| 251 | ARCT | Arcturus Therapeutics Holdings Inc. | 389.11M | -0.07% | 592,981 | 29.37M |
| 252 | VTVT | vTv Therapeutics Inc. | 383.93M | 3.00% | 30,936 | 36.84M |
| 253 | ENTA | Enanta Pharmaceuticals, Inc. | 383.87M | 4.27% | 425,882 | 65.26M |
| 254 | SRZN | Surrozen, Inc. | 378.23M | 0.63% | 1,656,606 | 11.51M |
| 255 | OBIO | Orchestra BioMed Holdings, Inc. | 373.85M | 2.30% | 277,376 | 31.98M |
| 256 | FENC | Fennec Pharmaceuticals Inc. | 373.47M | -1.39% | 149,207 | 59.22M |
| 257 | IKT | Inhibikase Therapeutics, Inc. | 373.25M | 1.49% | 579,457 | 1.00 |
| 258 | OCGN | Ocugen, Inc. | 349.28M | -5.50% | 7,322,871 | 4.58M |
| 259 | BNTC | Benitec Biopharma Inc. | 348.83M | 2.56% | 145,985 | - |
| 260 | SCTX | Scribe Therapeutics Inc. | 348.44M | -20.08% | 1,183,388 | 33.30M |
| 261 | ARTV | Artiva Biotherapeutics, Inc. | 348.10M | 1.28% | 383,973 | 251.00K |
| 262 | VOGX | Vogenx, Inc. | 338.55M | -6.29% | 79,214 | - |
| 263 | LRMR | Larimar Therapeutics, Inc. | 333.50M | 1.75% | 1,496,982 | - |
| 264 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 327.51M | 4.21% | 736,319 | - |
| 265 | CABA | Cabaletta Bio, Inc. | 325.53M | -3.03% | 8,052,025 | - |
| 266 | IPSC | Century Therapeutics, Inc. | 309.64M | 3.64% | 624,209 | 109.16M |
| 267 | INDP | Indaptus Therapeutics, Inc. | 306.46M | -19.30% | 643,048 | - |
| 268 | CUVL | Clinuvel Pharmaceuticals Limited | 301.59M | 1.53% | 13,135 | 65.05M |
| 269 | ABEO | Abeona Therapeutics Inc. | 300.22M | 1.74% | 1,130,668 | 25.52M |
| 270 | EVMN | Evommune, Inc. | 299.77M | -1.08% | 724,169 | 10.00M |
| 271 | VNDA | Vanda Pharmaceuticals Inc. | 296.87M | -2.39% | 3,077,040 | 215.72M |
| 272 | RCKT | Rocket Pharmaceuticals, Inc. | 288.71M | 1.54% | 2,526,773 | - |
| 273 | SABS | SAB Biotherapeutics, Inc. | 288.43M | -1.55% | 487,574 | 114.70K |
| 274 | UPB | Upstream Bio, Inc. | 288.10M | 1.35% | 851,212 | 3.16M |
| 275 | XFOR | X4 Pharmaceuticals, Inc. | 287.53M | - | 1,764,641 | 15.85M |
| 276 | FATE | Fate Therapeutics, Inc. | 283.97M | -0.42% | 1,078,057 | 6.49M |
| 277 | FULC | Fulcrum Therapeutics, Inc. | 282.30M | - | 1,918,377 | 80.00M |
| 278 | EYPT | EyePoint, Inc. | 281.91M | -4.39% | 3,437,228 | 2.79M |
| 279 | LXEO | Lexeo Therapeutics, Inc. | 277.30M | -1.17% | 3,053,791 | - |
| 280 | VCRE | Vicore Pharma Holding AB (publ) | 270.18M | -0.11% | 20,120 | 412.09K |
| 281 | STRO | Sutro Biopharma, Inc. | 267.12M | 0.06% | 133,947 | 45.70M |
| 282 | IFRX | InflaRx N.V. | 265.26M | -2.70% | 302,498 | -11.54K |
| 283 | GLSI | Greenwich LifeSciences, Inc. | 264.94M | -1.80% | 145,015 | - |
| 284 | IMRX | Immuneering Corporation | 264.94M | -0.85% | 596,819 | - |
| 285 | ZNTL | Zentalis Pharmaceuticals, Inc. | 262.24M | 2.03% | 1,011,549 | 26.87M |
| 286 | ACIU | AC Immune SA | 259.50M | 0.38% | 199,643 | 21.67M |
| 287 | BCYC | Bicycle Therapeutics plc | 257.57M | 0.82% | 295,137 | 61.21M |
| 288 | IVVD | Invivyd, Inc. | 256.47M | 2.35% | 8,385,724 | 58.37M |
| 289 | CAMP | Camp4 Therapeutics Corporation | 253.52M | 3.32% | 170,661 | 4.22M |
| 290 | QTTB | Q32 Bio Inc. | 246.19M | -13.22% | 5,250,505 | 53.74M |
| 291 | MGNX | MacroGenics, Inc. | 245.88M | 2.39% | 634,043 | 175.14M |
| 292 | SLGL | Sol-Gel Technologies Ltd. | 243.19M | 2.81% | 39,180 | 1.80M |
| 293 | LCTX | Lineage Cell Therapeutics, Inc. | 241.70M | 0.87% | 1,090,154 | 13.08M |
| 294 | LYEL | Lyell Immunopharma, Inc. | 239.91M | 1.66% | 153,932 | 27.00K |
| 295 | SION | Sionna Therapeutics, Inc. | 237.82M | 2.14% | 1,157,751 | - |
| 296 | PALI | Palisade Bio, Inc. | 235.27M | -6.90% | 4,765,609 | 500.00K |
| 297 | PRQR | ProQR Therapeutics N.V. | 234.26M | 0.61% | 678,470 | 21.05M |
| 298 | TRDA | Entrada Therapeutics, Inc. | 228.96M | 1.44% | 239,805 | 4.69M |
| 299 | KROS | Keros Therapeutics, Inc. | 225.83M | 1.79% | 131,215 | 15.01M |
| 300 | CGEN | Compugen Ltd. | 225.44M | 1.28% | 118,236 | 74.00M |
| 301 | PLX | Protalix BioTherapeutics, Inc. | 222.38M | 2.60% | 836,259 | 80.62M |
| 302 | RNAC | Cartesian Therapeutics, Inc. | 218.14M | -0.41% | 166,941 | 1.48M |
| 303 | ADAG | Adagene Inc. | 214.86M | -0.31% | 254,271 | 9.29M |
| 304 | WHWK | Whitehawk Therapeutics, Inc. | 214.35M | 0.80% | 265,594 | 7.15M |
| 305 | FHTX | Foghorn Therapeutics Inc. | 212.01M | 1.42% | 419,957 | 36.74M |
| 306 | YARW | Yarrow Bioscience, Inc. | 207.63M | -7.75% | 105,698 | - |
| 307 | ALEC | Alector, Inc. | 206.57M | -1.07% | 792,696 | 13.86M |
| 308 | ELDN | Eledon Pharmaceuticals, Inc. | 205.79M | 1.20% | 717,488 | - |
| 309 | NGEN | NervGen Pharma Corp. | 205.37M | -0.52% | 548,693 | - |
| 310 | ANTX | AN2 Therapeutics, Inc. | 200.76M | 4.52% | 199,204 | - |
| 311 | ACOG | Alpha Cognition Inc. | 196.00M | 3.33% | 147,013 | 15.26M |
| 312 | PYXS | Pyxis Oncology, Inc. | 194.34M | -19.66% | 8,149,518 | 11.04M |
| 313 | ORMP | Oramed Pharmaceuticals Inc. | 194.26M | -0.43% | 129,150 | 2.00M |
| 314 | ALXO | ALX Oncology Holdings Inc. | 192.21M | 2.96% | 1,344,369 | - |
| 315 | CNTN | Canton Strategic Holdings, Inc. | 189.24M | -0.21% | 445,860 | 1.50M |
| 316 | CUE | Cue Biopharma, Inc. | 187.93M | 1.41% | 228,050 | 37.66M |
| 317 | NKTX | Nkarta, Inc. | 187.66M | - | 283,149 | - |
| 318 | CMPX | Compass Therapeutics, Inc. | 187.29M | -5.45% | 5,656,969 | 850.00K |
| 319 | AVXL | Anavex Life Sciences Corp. | 187.25M | -14.41% | 2,965,017 | - |
| 320 | CHRS | Coherus Oncology, Inc. | 186.95M | 2.54% | 1,579,779 | 50.94M |
| 321 | NAUT | Nautilus Biotechnology, Inc. | 180.70M | 4.03% | 12,786,321 | 190.00K |
| 322 | MSLE | Satellos Bioscience Inc. | 180.68M | -1.45% | 89,165 | - |
| 323 | TARA | Protara Therapeutics, Inc. | 180.24M | -4.98% | 8,824,866 | - |
| 324 | MDWD | MediWound Ltd. | 178.42M | 0.14% | 83,887 | 11.86M |
| 325 | VRXA | Veraxa Biotech AG | 176.76M | -4.58% | 119,482 | 29.54K |
| 326 | DTIL | Precision BioSciences, Inc. | 172.79M | 1.29% | 249,244 | 45.06M |
| 327 | PEPG | PepGen Inc. | 167.61M | 3.42% | 2,151,023 | - |
| 328 | TNXP | Tonix Pharmaceuticals Holding Corp. | 167.05M | 0.93% | 318,025 | 29.10M |
| 329 | VYGR | Voyager Therapeutics, Inc. | 165.14M | 1.52% | 598,763 | 34.46M |
| 330 | ABOS | Acumen Pharmaceuticals, Inc. | 160.54M | -1.11% | 1,482,823 | - |
| 331 | NERV | Minerva Neurosciences, Inc. | 159.95M | - | 79,317 | - |
| 332 | NBP | NovaBridge Biosciences | 158.34M | -0.36% | 250,297 | - |
| 333 | MOLN | Molecular Partners AG | 152.42M | 0.26% | 1,848 | 856.30K |
| 334 | CDXS | Codexis, Inc. | 152.21M | 2.96% | 909,824 | 77.68M |
| 335 | MENS | Jyong Biotech Ltd. | 152.18M | 0.99% | 31,326 | - |
| 336 | IPHA | Innate Pharma S.A. | 149.18M | 1.87% | 37,805 | 11.21M |
| 337 | KRRO | Korro Bio, Inc. | 145.93M | 3.66% | 108,134 | 2.38M |
| 338 | HUMA | Humacyte, Inc. | 143.82M | -2.82% | 5,748,653 | 2.12M |
| 339 | TLSA | Tiziana Life Sciences Ltd | 143.53M | 16.39% | 1,522,288 | - |
| 340 | RNA | Atrium Therapeutics, Inc. | 141.63M | -1.66% | 197,306 | 35.84M |
| 341 | SPRB | Spruce Biosciences, Inc. | 139.62M | 2.77% | 61,230 | 697.00K |
| 342 | OTLK | Outlook Therapeutics, Inc. | 139.62M | -8.34% | 9,011,677 | -1.16M |
| 343 | ARMP | Armata Pharmaceuticals, Inc. | 136.46M | 2.23% | 127,036 | 5.54M |
| 344 | CRBU | Caribou Biosciences, Inc. | 136.15M | 2.42% | 844,760 | 10.04M |
| 345 | TNYA | Tenaya Therapeutics, Inc. | 135.35M | 1.77% | 1,700,310 | 1.34M |
| 346 | ENGN | enGene Therapeutics Inc. | 134.03M | 2.56% | 1,283,136 | - |
| 347 | HURA | TuHURA Biosciences, Inc. | 133.83M | 1.45% | 284,445 | - |
| 348 | KZIA | Kazia Therapeutics Limited | 132.38M | -0.92% | 188,120 | 1.27M |
| 349 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 131.91M | 2.87% | 508,184 | - |
| 350 | UNCY | Unicycive Therapeutics, Inc. | 130.78M | 3.19% | 862,638 | - |
| 351 | IMUX | Immunic, Inc. | 126.89M | 4.38% | 448,493 | - |
| 352 | NRXP | NRx Pharmaceuticals, Inc. | 126.33M | - | 1,172,268 | 3.39M |
| 353 | INO | Inovio Pharmaceuticals, Inc. | 126.14M | 9.91% | 2,687,734 | 65.34K |
| 354 | PMVP | PMV Pharmaceuticals, Inc. | 126.11M | 16.78% | 3,125,240 | - |
| 355 | SEER | Seer, Inc. | 123.48M | 3.72% | 752,957 | 14.22M |
| 356 | CBUS | Cibus, Inc. | 123.05M | 3.87% | 276,267 | 4.35M |
| 357 | MIST | Milestone Pharmaceuticals Inc. | 121.99M | 5.57% | 1,268,816 | 2.34M |
| 358 | LENZ | LENZ Therapeutics, Inc. | 120.65M | -0.52% | 786,205 | 21.48M |
| 359 | COYA | Coya Therapeutics, Inc. | 117.99M | - | 101,358 | 8.02M |
| 360 | AARD | Aardvark Therapeutics, Inc. | 116.21M | -0.75% | 28,120 | - |
| 361 | VANI | Vivani Medical, Inc. | 113.66M | 2.44% | 119,113 | - |
| 362 | GNLX | Genelux Corporation | 113.37M | 3.27% | 236,868 | 8.00K |
| 363 | NMRA | Neumora Therapeutics, Inc. | 112.02M | -12.01% | 2,286,522 | - |
| 364 | OKUR | OnKure Therapeutics, Inc. | 110.35M | 4.81% | 831,386 | - |
| 365 | RANI | Rani Therapeutics Holdings, Inc. | 110.26M | -1.16% | 468,356 | 4.88M |
| 366 | CLLS | Cellectis S.A. | 110.21M | 2.72% | 67,405 | 63.82M |
| 367 | BDTX | Black Diamond Therapeutics, Inc. | 108.30M | 0.80% | 551,806 | 70.00M |
| 368 | TENX | Tenax Therapeutics, Inc. | 108.26M | 2.72% | 4,223,443 | - |
| 369 | PYPD | PolyPid Ltd. | 107.04M | -0.38% | 47,389 | - |
| 370 | TVGN | Tevogen Inc. | 104.18M | -1.93% | 1,713 | - |
| 371 | PLYX | Polaryx Therapeutics, Inc. | 103.18M | - | 16,526 | - |
| 372 | EQ | Equillium, Inc. | 103.04M | 0.31% | 3,104,244 | 4.39M |
| 373 | ANIX | Anixa Biosciences, Inc. | 101.86M | 2.81% | 430,330 | - |
| 374 | CNXU | Conexeu Sciences Inc. | 100.70M | -3.77% | 194,861 | - |
| 375 | PMN | ProMIS Neurosciences, Inc. | 97.30M | 1.97% | 12,682 | - |
| 376 | BMEA | Biomea Fusion, Inc. | 96.40M | 5.56% | 1,453,276 | - |
| 377 | CRDF | Cardiff Oncology, Inc. | 94.13M | 3.42% | 564,613 | 508.00K |
| 378 | NRXS | NeurAxis, Inc. | 92.55M | -5.03% | 81,896 | 5.32M |
| 379 | NTRB | Nutriband Inc. | 91.41M | -8.85% | 147,736 | 1.62M |
| 380 | CGTX | Cognition Therapeutics, Inc. | 91.29M | 0.59% | 386,101 | - |
| 381 | RLYB | Rallybio Corporation | 90.81M | -0.70% | 5,418 | 646.00K |
| 382 | ICCC | ImmuCell Corporation | 89.91M | -0.40% | 2,286 | 30.68M |
| 383 | ACRV | Acrivon Therapeutics, Inc. | 87.85M | -1.44% | 176,934 | - |
| 384 | GUTS | Fractyl Health, Inc. | 86.66M | 4.69% | 2,153,721 | 3.00K |
| 385 | ATRA | Atara Biotherapeutics, Inc. | 85.32M | 5.59% | 29,301 | 6.19M |
| 386 | ONCY | Oncolytics Biotech Inc. | 85.20M | -0.93% | 866,941 | - |
| 387 | NTHI | NeOnc Technologies Holdings, Inc. | 84.64M | 3.18% | 131,723 | 39.99K |
| 388 | TELO | Telomir Pharmaceuticals, Inc. | 82.53M | 2.56% | 43,296 | - |
| 389 | MNOV | MediciNova, Inc. | 82.45M | -12.76% | 370,155 | 920.48K |
| 390 | VRCA | Verrica Pharmaceuticals Inc. | 82.37M | 7.51% | 50,861 | 30.32M |
| 391 | PTHS | Pelthos Therapeutics Inc. | 80.44M | 0.43% | - | 43.30M |
| 392 | ACET | Adicet Bio, Inc. | 76.86M | 4.54% | 210,842 | - |
| 393 | IBIO | iBio, Inc. | 75.88M | 0.85% | 229,671 | 100.00K |
| 394 | GANX | Gain Therapeutics, Inc. | 75.50M | 2.98% | 787,967 | - |
| 395 | ALDX | Aldeyra Therapeutics, Inc. | 74.20M | -6.82% | 1,651,199 | - |
| 396 | OSTX | OS Therapies Incorporated | 73.80M | -0.62% | 475,091 | - |
| 397 | GOSS | Gossamer Bio, Inc. | 72.41M | 2.33% | 381,776 | 53.29M |
| 398 | CING | Cingulate Inc. | 71.98M | 0.92% | 66,803 | - |
| 399 | MAIA | MAIA Biotechnology, Inc. | 71.77M | 2.61% | 684,474 | - |
| 400 | FBIO | Fortress Biotech, Inc. | 71.37M | -2.73% | 221,166 | 68.47M |
| 401 | SPRO | Spero Therapeutics, Inc. | 70.46M | 0.83% | 558,213 | 47.00M |
| 402 | RNXT | RenovoRx, Inc. | 70.40M | -0.64% | 397,957 | 1.98M |
| 403 | CSBR | Champions Oncology, Inc. | 69.59M | 4.38% | 35,206 | 60.66M |
| 404 | RNTX | Rein Therapeutics Inc. | 69.36M | 1.77% | 418,972 | - |
| 405 | CNTB | Connect Biopharma Holdings Limited | 69.27M | 10.89% | 165,632,579 | 2.95M |
| 406 | KLRS | Kalaris Therapeutics, Inc. | 68.80M | -0.34% | 102,556 | - |
| 407 | OKYO | OKYO Pharma Limited | 67.70M | -5.15% | 6,008 | - |
| 408 | XBIT | XBiotech Inc. | 67.07M | 0.92% | 62,845 | - |
| 409 | PLRX | Pliant Therapeutics, Inc. | 66.88M | - | 238,679 | - |
| 410 | ALPS | Alps Group Inc | 66.23M | -0.48% | 57,496 | 3.74M |
| 411 | MREO | Mereo BioPharma Group plc | 64.20M | 7.72% | 3,067,152 | 500.00K |
| 412 | INKT | MiNK Therapeutics, Inc. | 64.04M | 2.37% | 61,135 | - |
| 413 | ELOX | Eloxx Pharmaceuticals, Inc. | 63.29M | 1.69% | 13,664 | - |
| 414 | HYFT | MindWalk Holdings Corp. | 62.42M | -3.99% | 101,884 | 11.57M |
| 415 | ATHE | Alterity Therapeutics Limited | 61.77M | -0.27% | 30,346 | 2.50M |
| 416 | XLO | Xilio Therapeutics, Inc. | 59.55M | 1.23% | 5,378 | 64.09M |
| 417 | HRTX | Heron Therapeutics, Inc. | 59.52M | 2.45% | 2,472,404 | 151.18M |
| 418 | HYPD | Hyperion DeFi, Inc. | 58.20M | -6.14% | 853,873 | 1.40M |
| 419 | CLNN | Clene Inc. | 57.99M | -0.49% | 52,007 | 197.00K |
| 420 | BOLD | Boundless Bio, Inc. | 57.09M | -1.95% | 208,240 | - |
| 421 | EDSA | Edesa Biotech, Inc. | 56.88M | 18.26% | 84,410 | - |
| 422 | BSEM | BioStem Technologies, Inc. | 55.15M | -19.32% | 332,899 | 34.59M |
| 423 | APLM | Apollomics, Inc. | 54.79M | 3.44% | 1,303 | 8.84M |
| 424 | INMB | INmune Bio Inc. | 54.12M | -0.51% | 201,798 | 50.00K |
| 425 | EXOZ | eXoZymes, Inc. | 54.11M | -4.43% | 2,034 | -700.00 |
| 426 | ANVS | Annovis Bio, Inc. | 54.11M | -2.31% | 572,994 | - |
| 427 | IMA | ImageneBio, Inc. | 51.99M | - | 9,177 | 800.00K |
| 428 | SER | Serina Therapeutics, Inc. | 50.80M | -3.85% | 10,858 | 130.00K |
| 429 | TIL | Instil Bio, Inc. | 49.03M | 1.26% | 8,701 | - |
| 430 | IBO | Impact BioMedical Inc. | 47.85M | - | - | 35.00K |
| 431 | ELTX | Elicio Therapeutics, Inc. | 47.83M | -1.09% | 274,030 | - |
| 432 | DWTX | Dogwood Therapeutics, Inc. | 45.89M | - | 34,319 | - |
| 433 | VERU | Veru Inc. | 45.35M | 3.91% | 182,956 | 16.89M |
| 434 | GRCE | Grace Therapeutics, Inc. | 45.23M | 1.90% | 25,339 | - |
| 435 | CRVO | CervoMed Inc. | 44.90M | 3.13% | 375,542 | 331.30K |
| 436 | HOWL | Werewolf Therapeutics, Inc. | 44.82M | 1.35% | 829,167 | 21.00M |
| 437 | CELU | Celularity Inc. | 43.81M | -1.46% | 55,428 | 27.12M |
| 438 | FLNA | Filana Therapeutics, Inc. | 42.80M | -4.19% | 776,905 | - |
| 439 | PDSB | PDS Biotechnology Corporation | 42.02M | 1.05% | 4,585,569 | - |
| 440 | LITS | Lite Strategy, Inc. | 40.14M | -4.00% | 331,255 | - |
| 441 | MGX | Metagenomi Therapeutics, Inc. | 40.04M | -6.19% | 152,288 | 13.56M |
| 442 | BCTX | BriaCell Therapeutics Corp. | 37.38M | 4.90% | 90,361 | - |
| 443 | CVM | CEL-SCI Corporation | 36.23M | 15.08% | 479,379 | - |
| 444 | ATNM | Actinium Pharmaceuticals, Inc. | 35.21M | -1.75% | 95,130 | 35.09M |
| 445 | ALGS | Aligos Therapeutics, Inc. | 35.16M | 0.18% | 35,278 | 31.52M |
| 446 | IMMP | Immutep Limited | 34.95M | -1.27% | 10,477 | 13.79M |
| 447 | LONA | LeonaBio, Inc. | 33.64M | 1.71% | 40,253 | - |
| 448 | MCRB | Seres Therapeutics, Inc. | 33.30M | -3.74% | 54,611 | 1.88M |
| 449 | NNVC | NanoViricides, Inc. | 33.18M | - | 426,614 | - |
| 450 | BYSI | BeyondSpring Inc. | 31.66M | -0.43% | 268,862 | 1.88M |
| 451 | QNCX | Quince Therapeutics, Inc. | 31.65M | -0.16% | 10,181 | - |
| 452 | ATYR | aTyr Pharma, Inc. | 29.72M | -1.53% | 1,802,423 | 190.00K |
| 453 | QNTM | Quantum BioPharma Ltd. | 29.12M | -5.76% | 114,059 | - |
| 454 | RNAZ | TransCode Therapeutics, Inc. | 28.44M | 3.07% | 6,670 | - |
| 455 | IGC | IGC Pharma, Inc. | 27.80M | 0.52% | 812,169 | 1.11M |
| 456 | KPTI | Karyopharm Therapeutics Inc. | 27.67M | 1.24% | 1,753,671 | 146.62M |
| 457 | CNTX | Context Therapeutics Inc. | 27.60M | -5.83% | 1,193,750 | - |
| 458 | ABVC | ABVC BioPharma, Inc. | 27.48M | 1.92% | 55,176 | 797.92K |
| 459 | EVAX | Evaxion A/S | 27.36M | 0.31% | 18,052 | 7.49M |
| 460 | KYNB | Kyntra Bio, Inc. | 26.93M | -2.06% | 25,471 | 4.62M |
| 461 | GRDX | GridAI Technologies Corp. | 26.07M | 12.94% | 120,501 | - |
| 462 | PLRZ | Polyrizon Ltd. | 25.90M | 2.79% | 11,418 | - |
| 463 | NXTC | NextCure, Inc. | 22.93M | 3.41% | 34,138 | - |
| 464 | COCP | Cocrystal Pharma, Inc. | 22.92M | 6.25% | 12,665 | 330.00K |
| 465 | QNRX | Quoin Pharmaceuticals, Ltd. | 21.91M | -6.56% | 139,173 | - |
| 466 | TCRX | TScan Therapeutics, Inc. | 21.32M | -0.94% | 554,407 | 7.11M |
| 467 | PBM | Psyence Biomedical Ltd. | 20.83M | 0.55% | 17,930 | - |
| 468 | ESLA | Estrella Immunopharma, Inc. | 20.30M | 1.43% | 18,381 | - |
| 469 | ATOS | Atossa Therapeutics, Inc. | 19.46M | -2.01% | 67,712 | - |
| 470 | JSPR | Jasper Therapeutics, Inc. | 19.30M | -7.26% | 540,198 | - |
| 471 | NEUP | Neuphoria Therapeutics Inc. | 19.26M | -0.28% | 10,391 | 1.17M |
| 472 | ACTU | Actuate Therapeutics, Inc. | 18.72M | 13.66% | 410,453 | - |
| 473 | LPCN | Lipocine Inc. | 18.14M | 1.85% | 31,368 | 1.57M |
| 474 | RADX | Radiopharm Theranostics Limited | 18.10M | 5.26% | 63,298 | 9.34M |
| 475 | AKTX | Akari Therapeutics, Plc | 17.97M | -5.04% | 46,967 | - |
| 476 | MRKR | Marker Therapeutics, Inc. | 17.84M | -2.73% | 38,387 | 3.55M |
| 477 | NCEL | NewcelX Ltd. | 17.76M | 3.54% | 2,724 | - |
| 478 | CLRB | Cellectar Biosciences, Inc. | 17.39M | 1.10% | 74,862 | - |
| 479 | ICU | SeaStar Medical Holding Corporation | 17.36M | 10.67% | 86,699 | 1.71M |
| 480 | KTTA | Pasithea Therapeutics Corp. | 16.90M | 3.20% | 59,995 | - |
| 481 | PTN | Palatin Technologies, Inc. | 16.76M | -2.74% | 21,514 | 13.19M |
| 482 | ALLR | Allarity Therapeutics, Inc. | 16.71M | 8.80% | 119,063 | 345.00K |
| 483 | TVRD | Tvardi Therapeutics, Inc. | 16.67M | -2.34% | 232,642 | - |
| 484 | KPRX | Kiora Pharmaceuticals, Inc. | 16.29M | -1.54% | 2,269 | 20.00K |
| 485 | DYAI | Dyadic International, Inc. | 16.20M | -4.59% | 86,809 | 3.80M |
| 486 | BCDA | BioCardia, Inc. | 15.29M | -1.94% | 99,613 | 3.00K |
| 487 | AEON | AEON Biopharma, Inc. | 14.96M | 15.83% | 116,174,743 | - |
| 488 | PASG | Passage Bio, Inc. | 14.79M | -0.76% | 28,926 | - |
| 489 | CTXR | Citius Pharmaceuticals, Inc. | 14.58M | -4.24% | 127,488 | 7.11M |
| 490 | NIKI | Niki BioSolutions, Inc. | 14.40M | 3.38% | 4,617 | - |
| 491 | CNSY | Cerenome, Inc. | 14.19M | 0.54% | 226,526 | 4.20M |
| 492 | HIND | Vyome Holdings, Inc. | 14.11M | -0.50% | 7,489 | 129.73K |
| 493 | TPST | Tempest Therapeutics, Inc. | 13.80M | 2.96% | 266,103 | - |
| 494 | VTGN | Vistagen Therapeutics, Inc. | 13.66M | 3.29% | 2,427,306 | 2.50M |
| 495 | INAB | IN8bio, Inc. | 13.21M | 3.47% | 30,299 | - |
| 496 | DARE | Daré Bioscience, Inc. | 13.05M | 4.70% | 278,067 | 1.37M |
| 497 | LSTA | Lisata Therapeutics, Inc. | 12.98M | -2.04% | 17,080 | 100.00K |
| 498 | LTRN | Lantern Pharma Inc. | 12.91M | -6.91% | 420,704 | - |
| 499 | PLUR | Pluri Inc. | 12.34M | -0.89% | 6,990 | 1.02M |
| 500 | PHIO | Phio Pharmaceuticals Corp. | 11.97M | - | 103,992 | - |